I. Brown

International validation of a risk prediction algorithm for patients with malignant colorectal polyps

P. Kumarasinghe, G. Ramsay, T. Eglinton, 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Evaluation of Serum Glycoprotein Biomarker Candidates for Detection of Esophageal Adenocarcinoma and Surveillance of Barrett's Esophagus*

A. Barbour, D. Whiteman, B. Spicer, 2018, Molecular & Cellular Proteomics.

Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid‐induced DNA damage

J. Westerhuis, A. Barbour, M. Hodson, 2022, Clinical and translational medicine.

C5b-9 Membrane Attack Complex Formation and Extracellular Vesicle Shedding in Barrett’s Esophagus and Esophageal Adenocarcinoma

A. Barbour, G. Eslick, Alain Wuethrich, 2022, Frontiers in Immunology.

Serum glycoprotein biomarker validation for esophageal adenocarcinoma and application to Barrett’s surveillance

A. Barbour, D. Whiteman, B. Spicer, 2018, bioRxiv.

Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma

J. Emery, M. Appleyard, D. Whiteman, 2015, Journal of gastroenterology and hepatology.

Risk Stratification for Early Esophageal Adenocarcinoma: Analysis of Lymphatic Spread and Prognostic Factors

A. Barbour, D. Gotley, A. Clouston, 2010, Annals of Surgical Oncology.